NCT06591663 Can Cognitive Therapy Rating Scale (CTRS) be Used Across Cultures? Enhancing Cultural Relevance of CTRS
| NCT ID | NCT06591663 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pakistan Association of Cognitive Therapists |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-09-08 |
| Primary Completion | 2024-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-09-08 with a primary completion date of 2024-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Translate and adapt the Cognitive Therapy Rating Scale (CTRS) into Urdu language and establishing the psychometric properties (reliability, validity, and norms) of the translated scale
Eligibility Criteria
Inclusion Criteria: * Individuals aged 18 to 65 years At least 5 years of education Score of 8 or higher on Hospital Anxiety and Depression Scale-Depression or Anxiety scales as measured by their primary care clinician Exclusion Criteria: * Substance use disorder according to DSM-5 TR criteria Significant cognitive impairment (for example, profound learning disability or dementia) Active psychosis as determined by their primary care clinician
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06591663 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06591663 currently recruiting?
Yes, NCT06591663 is actively recruiting participants. Contact the research team at sadia.abid22@gmail.com for enrollment information.
Where is the NCT06591663 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06591663 clinical trial?
NCT06591663 is sponsored by Pakistan Association of Cognitive Therapists. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.